Patent intelligence · US
US 7910126
Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same
Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same
Patent details — US 7910126
- Jurisdiction
- US
- Status
- granted
- Grant date
- Mar 22, 2011
- Expiration
- Mar 17, 2031
- Applicant
- TEVA WOMEN'S HEALTH, INC.
- Claims
- 28
- CPC classes
- A61K, A61K31/00, A61K31/20, A61K38/00
Quick answer
US 7910126 (Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same) is held by TEVA WOMEN'S HEALTH, INC.. Status: granted. Granted Mar 22, 2011. Expires Mar 17, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- TEVA WOMEN'S HEALTH, INC.
- Grant date
- Expiration
- Claims
- 28
- CPC classes
- A61K, A61K31/00, A61K31/20, A61K38/00, A61K9/0036, A61P
More from TEVA WOMEN'S HEALTH, INC.
Related pharmaceutical patents in our USPTO index.
-
US 12310929
Use of rasagiline for the treatment of restless legs syndrome
granted -
US 12258401
Anti-CD47 combination therapy
granted -
US 12157729
Solid state forms of Belumosudil and Belumosudil salts
granted -
US 12139528
Treating refractory migraine
granted -
US 12091388
Solid state forms of Reproxalap
granted -
US 11826322
Pre-filled syringe
granted -
US 11813359
Sustained release olanzapine formulations
granted -
US 11773083
Solid state forms of Belumosudil and Belumosudil salts
granted
Frequently asked questions
What is US patent 7910126?
US 7910126 (Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same) is held by TEVA WOMEN'S HEALTH, INC.. Status: granted. Granted Mar 22, 2011. Expires Mar 17, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7910126?
TEVA WOMEN'S HEALTH, INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 454 pharmaceutical patents for this assignee.
When does US 7910126 expire?
Our index shows an expiration date of Mar 17, 2031 (5 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.